HB Wealth Management LLC Sells 7,369 Shares of Lam Research Corporation $LRCX

Key Points

• HB Wealth Management reduced its Lam Research stake by 6.5%, selling 7,369 shares and retaining 106,838 shares valued at approximately $46.3 million. Institutional investors collectively own 84.61% of the company.
• Analysts remain broadly positive, with Lam Research carrying a “Moderate Buy” consensus rating and an average price target of $358.97, despite some firms recently lowering targets.
• Lam Research reported strong quarterly results, including $6.72 billion in revenue—up 30% year over year—and earnings of $1.82 per share, beating estimates. The company also raised its quarterly dividend from $0.26 to $0.33 per share.

HB Wealth Management LLC lowered its position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 6.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 106,838 shares of the semiconductor company's stock after selling 7,369 shares during the period. HB Wealth Management LLC's holdings in Lam Research were worth $46,296,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. State Street Corp increased its position in Lam Research by 0.4% during the 3rd quarter. State Street Corp now owns 59,817,352 shares of the semiconductor company's stock valued at $8,024,684,000 after purchasing an additional 265,805 shares during the period. Geode Capital Management LLC raised its holdings in shares of Lam Research by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 33,747,368 shares of the semiconductor company's stock valued at $5,764,117,000 after purchasing an additional 126,613 shares in the last quarter. Invesco Ltd. lifted its position in shares of Lam Research by 7.7% in the 4th quarter. Invesco Ltd. now owns 22,821,354 shares of the semiconductor company's stock worth $3,906,559,000 after purchasing an additional 1,638,406 shares during the period. Norges Bank purchased a new stake in shares of Lam Research in the 4th quarter worth approximately $3,645,427,000. Finally, Price T Rowe Associates Inc. MD boosted its stake in shares of Lam Research by 352.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company's stock valued at $2,344,347,000 after purchasing an additional 10,666,540 shares in the last quarter. 84.61% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. TD Cowen reissued a "buy" rating and set a $400.00 price objective (up from $340.00) on shares of Lam Research in a report on Thursday, July 9th. B. Riley Financial lowered their target price on Lam Research from $385.00 to $350.00 and set a "buy" rating for the company in a report on Thursday, July 30th. Barclays reaffirmed an "overweight" rating and set a $335.00 target price (up from $275.00) on shares of Lam Research in a research report on Thursday, June 11th. Citigroup reiterated a "buy" rating and issued a $450.00 price target (up from $315.00) on shares of Lam Research in a report on Wednesday, June 17th. Finally, Mizuho reduced their price target on Lam Research from $370.00 to $365.00 and set an "outperform" rating for the company in a research report on Tuesday, August 25th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Lam Research currently has an average rating of "Moderate Buy" and a consensus target price of $358.97.

Lam Research Trading Up 5.1%

NASDAQ LRCX opened at $307.65 on Friday. Lam Research Corporation has a 52 week low of $100.68 and a 52 week high of $438.50. The company has a 50 day moving average price of $321.34 and a 200 day moving average price of $291.39. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. The firm has a market cap of $384.97 billion, a PE ratio of 53.41, a price-to-earnings-growth ratio of 1.22 and a beta of 1.85.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The company had revenue of $6.72 billion during the quarter, compared to the consensus estimate of $6.66 billion. During the same period last year, the firm earned $1.33 earnings per share. Lam Research's revenue was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, sell-side analysts forecast that Lam Research Corporation will post 9.33 EPS for the current fiscal year.

Lam Research Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be issued a dividend of $0.33 per share. The ex-dividend date is Wednesday, September 23rd. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. This is a boost from Lam Research's previous quarterly dividend of $0.26. Lam Research's dividend payout ratio (DPR) is currently 22.92%.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
• Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
• Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
• Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
• Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
• Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
• Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target

Insider Transactions at Lam Research

In related news, insider Ava Harter sold 5,000 shares of the company's stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the transaction, the insider directly owned 42,462 shares of the company's stock, valued at $12,843,056.52. This represents a 10.53% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the sale, the director owned 87,142 shares of the company's stock, valued at approximately $29,192,570. This trade represents a 17.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 77,782 shares of company stock valued at $26,755,370 in the last quarter. 0.31% of the stock is currently owned by corporate insiders.

Lam Research Company Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.